Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats

Humbert, 2004, Treatment of pulmonary arterial hypertension, N Engl J Med, 351, 1425, 10.1056/NEJMra040291

Martens, 2002, Metabolic and additional vascular effects of thiazolidinediones, Drugs, 62, 1463, 10.2165/00003495-200262100-00004

Meng, 2015, Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ2 in macrophages, Cell Physiol Biochem, 35, 689, 10.1159/000369729

Gao, 2015, Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells, PLoS One, 10, e0123724, 10.1371/journal.pone.0123724

Nicola, 2011, Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone, Am J Physiol Lung Cell Mol Physiol, 301, L125, 10.1152/ajplung.00074.2011

Jiang, 1998, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/34184

Morales-Garcia, 2011, Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo, Glia, 59, 293, 10.1002/glia.21101

Kulkarni, 2011, PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: Implications for therapy of fibrosis, PLoS One, 6, e15909, 10.1371/journal.pone.0015909

Nisbet, 2010, Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model, Am J Respir Cell Mol Biol, 412, 482, 10.1165/rcmb.2008-0132OC

Ochoa, 2010, Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension, J Cardiothorac Surg, 5, 32, 10.1186/1749-8090-5-32

Wang, 2009, Effects and mechanism of oridonin on pulmonary hypertension induced by chronic hypoxia-hypercapnia in rats, Chin Med J (Engl), 122, 1380

Ismail, 2009, NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: The role of autocrine production of transforming growth factor-{β}1 and insulin-like growth factor binding protein-3, Am J Physiol Lung Cell Mol Physiol, 296, L489, 10.1152/ajplung.90488.2008

Zhang, 2012, Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension, Microvasc Res, 84, 286, 10.1016/j.mvr.2012.06.010

Goncharova, 2002, PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells, Am J Physiol Lung Cell Mol Physiol, 283, L354, 10.1152/ajplung.00010.2002

Fenton, 2012, Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240, Proc Natl Acad Sci USA, 109, 14164, 10.1073/pnas.1211962109

Ying, 2011, PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network, Cancer Discov, 1, 158, 10.1158/2159-8290.CD-11-0031

Zhang, 2010, MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC), Clin Chim Acta, 411, 846, 10.1016/j.cca.2010.02.074

Oudit, 2009, Cardiac regulation by phosphoinositide 3-kinases and PTEN, Cardiovasc Res, 82, 250, 10.1093/cvr/cvp014

Oudit, 2004, The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease, J Mol Cell Cardiol, 37, 449, 10.1016/j.yjmcc.2004.05.015

Chen, 2013, SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas, Cancer Cell, 23, 826, 10.1016/j.ccr.2013.05.002

De Luca, 2012, The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches, Expert Opin Ther Targets, 16, S17, 10.1517/14728222.2011.639361

Moon, 2013, PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line, Int J Oncol, 42, 921, 10.3892/ijo.2013.1765

Conley-LaComb, 2013, PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling, Mol Cancer, 12, 85, 10.1186/1476-4598-12-85

Akca, 2013, Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines, J Enzyme Inhib Med Chem, 28, 539, 10.3109/14756366.2011.654114

Kitagishi, 2013, Redox regulation of tumor suppressor PTEN in cancer and aging (Review), Int J Mol Med, 31, 511, 10.3892/ijmm.2013.1235

Monsalve, 2013, Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases, Mediators Inflamm, 2013, 549627, 10.1155/2013/549627

Nickkho-Amiry, 2012, Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma, Mol Cancer Res, 10, 441, 10.1158/1541-7786.MCR-11-0233

O'Sullivan, 2010, Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease, Immunobiology, 215, 611, 10.1016/j.imbio.2009.09.007

Robinson, 2009, Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease, Pharmacol Ther, 122, 246, 10.1016/j.pharmthera.2009.03.003

Stephen, 2013, PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis, Eur Respir J, 41, 425, 10.1183/09031936.00145009

Wang, 2014, Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma, Cell Death Dis, 5, e1155, 10.1038/cddis.2014.122

Crossno, 2007, Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling, Am J Physiol Lung Cell Mol Physiol, 292, L885, 10.1152/ajplung.00258.2006

Zhang, 2014, Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): An in vivo study in rats, Life Sci, 98, 39, 10.1016/j.lfs.2013.12.208

Nicol, 2005, PPARgamma in endothelial cells influences high fat diet-induced hypertension, Am J Hypertens, 18, 549, 10.1016/j.amjhyper.2004.10.032

Hansmann, 2008, An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension, J Clin Invest, 118, 1846, 10.1172/JCI32503

Lu, 2013, Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells, Free Radic Biol Med, 63, 151, 10.1016/j.freeradbiomed.2013.05.013

Liu, 2014, Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors, PPAR Res, 2014, 374075, 10.1155/2014/374075

Kang, 2013, Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature, PLoS One, 8, e79503, 10.1371/journal.pone.0079503